Cisplatin is a potent anti-cancer drug, which functions by cross-linking adjacent DNA guanine residues. However within one day of injection, 65~98% of the platinum in the blood plasma is proteinbound. It is generally accepted that cisplatin binds to methionine and histidine residues, but what is often underappreciated is that platinum from cisplatin has a 2+ charge and can form up to four bonds.
spectrometry has been proved to be an potent tool for analyzing cross-linking reaction mixtures. The high mass accuracy of FTICR MS can greatly reduce the number of candidates for cross-linking products, and in addition, its high resolution, the ability of allowing a "gas phase" purification to accumulate low intensity cross-linking product ions, and the ability to fragment large proteins or peptides extensively are critical for the unambiguous assignment of the cross-linking products and localization of the cross-linking sites. However, the identification of the cross-linked products can be still quite difficult due to the complexity of reaction mixtures. The cross-linking chemistry inevitably produces a variety of products, including unmodified peptides, multiply modified peptides, dead-end, intra-and inter-peptide cross-linking products all present in the same sample, which makes the detection and identification of low-abundance cross-linked products challenging. To overcome these challenges, significant effort has been dedicated to design new cross-linkers which can enrich cross-linked products via affinity tags, [8] [9] [10] or facilitate the identification of cross-linked products by introducing mass spectrometry-cleavable bonds [6] [7] or specific signature patterns, [10] [11] [12] [13] such as PIR (protein interaction reporter), 7 isotope-labeled cross-linkers [11] [12] or isotope-labeled proteins. 13 Although there is a broad range of cross-linking reagents available, they all target a few particular functional groups, generally primary amines, carboxylates, sulfhydryls, and free carbonyls (aldehyde groups generated via protein oxidation). 14 The limited choices of reactive groups have limited the application of cross-linking; moreover, some of the inherent chemical problems of existing functional groups also hinder the interpretation of cross-linking data. For example, the complexity of the reaction mixtures makes assignment difficult, and low charge states but high mass-to-charge (m/z) ions are often formed upon electrospray ionization when the cross-linking reagent reacts with primary amine groups of lysines and the amino terminus, which could otherwise carry a charge. Therefore, the development of MS identifiable cross-linkers which target new functional groups will be of benefit in the mapping of protein-protein interactions.
Cisplatin, cis-[Pt(NH 3 ) 2 Cl 2 ], is a widely used anticancer drug which exerts its cytotoxic effect by reacting with DNA and forms 1,2-intrastrand cross-links between adjacent guanines. 15 The DNA crosslinking ability of cisplatin and its analogs have been well documented. [15] [16] [17] [18] In addition, a new class of anticancer drugs with multinuclear platinum molecules linked by flexible arms is capable of forming long range inter-or intrastand cross-links. [19] [20] [21] A few studies have demonstrated the ability of platinum compounds to cross-link DNA with proteins. [22] [23] [24] However, up to 98% of the platinum in the blood plasma is protein-bound within one day of injection. 25 The binding of cisplatin to proteins is likely to be a primary cause of the side effects of such chemotherapies. However, the interactions of proteins with platinum compounds have not been extensively explored compared to DNA-Pt research.
The ability of a platinum complex to cross-link proteins has been unexpectedly observed by Guo et al., and their result shows that cisplatin can stabilize a multimeric complex of the human Ctr1 copper transporter by cross-linking adjacent proteins via methinone binding. 26 Recently, Hu et al. also found that cisplatin cross-links domains of albumin. 27 However, whether cisplatin can function as a crosslinking reagent has not been fully explored. Platinum(II) has a strong affinity for sulfur and nitrogen containing ligands, and the coordination sites are the side chains of methionine (Met), cysteine (Cys) and histidine (His), namely, thioether, sulfhydryl, and imidazole. 28 Thus, cross-linkers targeting these functional groups will broaden the application of cross-linking and contribute to the understanding of protein action. Here, the ability of cisplatin as a potential cross-linker is explored and demonstrated using standard peptides and the 16.8 kDa protein calmodulin (CaM), but was unsuccessfully tested with the 64 kDa protein hemoglobin. In addition, the features of cisplatin as a potential cross-linking reagent are discussed.
EXPERIMENTAL METHODS

Materials.
Angiotensin II, bombesin, bovine calmodulin (CaM), trypsin, ammonium acetate (CH 3 COONH 4 ), and ammonium bicarbonate (NH 4 HCO 3 ) were purchased from Sigma (St. Louis, MO).
HPLC grade methanol, acetic acid (HAc), and acetonitrile (ACN) were obtained from Fisher Scientific (Pittsburgh, PA). Cisplatin was synthesized and characterized by standard methods.
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Reaction of peptides with Cisplatin. Aqueous solutions of 1000 μM angiotensin II, 1000
μM bombesin, and 500 μM cisplatin were prepared and mixed to give 200 μL of an angiotensin II:bombesin:platinum complex solution at a molar concentration of 20 μM and a molar ratio of 1:1:3.
The sample was incubated at 37 ℃ for 24 h, the pH value was determined before and after the reaction, both were 6. The sample was diluted to 0.4 μM with 50% MeOH-1% CH 3 COOH buffer immediately before mass spectrometry analysis. (CAD) experiments, the parent ions were isolated using the first quadrupole (Q1), and were fragmented in the collision cell (q, typical collision energies ~10-25 eV), and then transmitted into the ICR cell for detection. For electron capture dissociation (ECD) experiments, the parent ions were isolated in Q1
Reaction of Proteins with
and externally accumulated in collision cell for 3-10 s. After being transferred and trapped in the Infinity ICR cell, 30 ions were irradiated with 1.5 eV electrons from a 1.7 A heated hollow cathode dispenser for 50 to 80 ms. Full spectra were internally calibrated using peptide (bombesin or digested CaM) peaks, CAD spectra were internally calibrated using known b ion masses of bombesin or y ion masses of CaM(37-74), ECD spectra were internally calibrated using known c ion masses of bombesin or c ion masses of CaM(107-126). The assigned mass tables for each spectrum are provided as supplementary information (Tables S2~S8) .
RESULTS
Intermolecular cross-linking of peptides. Angiotensin II and bombesin are small peptides both with potential histidine or methionine platinum binding sites; their amino acid sequences are shown in Figure S-1) ; in addition, platinum was also found to bind to the carboxyl group of N-terminal aspartic acid (Asp) residue in angiotensin II (a 1 +Pt ion in Figure S-1a) . [31] [32] We therefore chose these two peptides for the cross-linking studies.
Platinum(II) is normally square planar with four covalent bonds. Depending on the type and number of nucleophiles available and steric accessibility of peptides or proteins, all the ligands of cisplatin can also be substituted by nucleophilic species. [33] [34] [35] As shown in ions with mean absolute deviation 0.37 ppm (Table S- Although ECD has been reported to be problematic on Pt-bound proteins, 38 an ECD experiment was still tested in an effort to further localize the cross-linking sites. 31, 39 in which they showed that the macrochelates with κ 2 S M , N H coordination modes are favorable in weakly acidic solutions (3≤pH≤6).
In the same sample, bombesin was also detected to cross-link with another bombesin molecule. Table S-5 and Table S -6) , which is likely to be due to the symmetric structure after platinum binding, as shown in Figure S -3c.
Intramolecular cross-linking of Calmodulin.
Calmodulin (CaM) is a small 16.8 kDa acidic protein, containing 9 Met residues out of 148 amino acid residues (Table S-1). The Met residues in CaM play an important role in its versatility, and contribute as much as 46% of the exposed surface area of the hydrophobic patches on the calmodulin surface, 40 which makes CaM an interesting target for this cross-linking study. CaM and cisplatin were incubated in a 1:1 mixture at 37 ℃ in water for 24
hours, and then subjected to trypsin digestion at a CaM-cisplatin to enzyme ratio of 40:1 (w/w) at 37 ℃ for 4 h followed by ESI-FTMS analysis. In addition to the peaks which correlate with Pt binding to the tryptic digested peptides, a peak corresponding to the platinum cross-linked tryptic digest peptides CaM(107-126) and CaM(127-148) was observed at m/z 1018 (5+) with a mass error of -0.08 ppm, as shown in Figure 3a , which is overlapped with the 4+ charge state CaM(38-74) ion. [42] [43] An interesting phenomenon of cisplatin cross-links in calmodulin is that all the ligands of cisplatin are displaced, which rarely happens in cisplatin-DNA adducts. [44] [45] Similar results have also been observed in other Met-rich peptides or proteins upon reaction with cisplatin due to the translabilization effect. [33] [34] [35] In other words, once the displacement of chlorine by sulfur of at Met or Cys residue has occurred, the Pt-NH 3 bond trans to the sulfur is significantly labilized and thus the amine group is readily substituted.
Intermolecular cross-linking of protein.
Hemoglobin is a tetrameric heme-protein in the red cells of the blood in mammals and other animals; it contains two alpha and two beta subunits noncovalently bound, designated as α 2 β 2 . Each subunit has multiple potential platinum binding sites, as listed in Table S -1, the α unit has two Met, ten His, and one Cys residue; the β unit has one Met, nine
His and two Cys residues. Since hemoglobin is a well understood and easy to obtain protein, it was therefore of interest to investigate whether cisplatin can cross-link α and β subunits. Although the study of cisplatin-hemoglobin has been reported, 46 whether cisplain can cross-link hemoglobin complex subunits has not been explored.
Abundant α and β peaks along with peaks corresponding to platinum bound to either α or β subunits were detected ( Figure S-4) ; however, no peaks corresponding to cisplatin cross-linking between the α and β subunits were detected.
DISCUSSION
The cross-linking sites were identified and localized by FTICR MS because of its unsurpassed resolution and mass accuracy, and also its ability to extensively fragment large peptides by CAD and ECD fragmentation techniques. Sub-ppm mass accuracy is routinely achieved by SolariX FTICR MS (Table S-2 to Table S-9 ) which is critical for the assignment of all the peaks as the number of peptides with the same nominal mass but different amino acid sequence increases dramatically with the number of amino acid residues in the peptides. 5 In Figure 2a ), the mass difference between these two peaks is only 5.2 mDa; therefore, the high resolution (R=200,000) and mass accuracy (0.03 ppm) of this spectrum greatly aid the assignments of these two peaks. More importantly, the assignment of these two peaks is critical for localizing the cross-linking sites.
Although the above experiments and CAD and ECD data all show that cisplatin has the potential to be a peptide and protein cross-linker, in the development of a cross-linker, there are multiple characteristics that should be considered, such as chemical specificity, arm length, water solubility and cell membrane permeability, homobifunctional or heterobifunctional reactive groups, and cleavability. 14 In light of these considerations, the potential for cisplatin as a cross-linker is discussed below.
Chemical specificity. Although there are 20 different amino acids in protein structures, only a small number of protein functional groups comprise selectable targets for practical cross-linking studies.
In practice, only four protein functional groups (primary amines, carboxylates, sulfhydryls, and carbonyls) account for the vast majority of cross-linking and chemical modification sites. However, there are up to nine amino acids in proteins that are readily derivatizable at their side chains, including aspartic acid, glutamic acid, lysine, arginine, cysteine, histidine, tyrosine, methionine, and tryptophan.
These nine residues contain eight principal functional groups, in addition to primary amines, carboxylates, and sulfhydryls (or disulfides), thioethers, imidazoles, guanidinyl groups, phenolic and indolyl rings also have sufficient reactivity for modification reactions. on the other hand, platinum inherently has two positive charges, e.g. when the fragment {Pt(NH 3 ) 2 } 2+ binds, the cross-linking products observed often have higher charge states than the peptides or proteins alone.
Higher charge states not only promote the detection of cross-linking products without purification, but also result in a more comprehensive MS/MS fragmentation pattern and therefore assist in the identification of modification sites.
(2) Unique isotopic pattern. Challenges to identify cross-linked products by mass spectrometry have arisen due to the complexity of the cross-linking reaction mixtures and low abundance of the crosslinked species. As presented in Figure 1 , predominantly unmodified peptides, dead-end modified peptides, and a low abundance of inter-cross-linked peptides were detected.
To overcome the challenges, significant effort has been made to develop new cross-linkers to facilitate the identification of cross-linked species by introducing a signature pattern in the data via isotope-labeling, such as isotope labeling the cross-linking reagents or proteins, [11] [12] [13] proteolytic digestion in 18 O labeling water, 10 or by enriching cross-linked products, such as affinity tags. [7] [8] [9] [10] In many cross-linking applications, isotope labeling has greatly facilitated the identification of cross-linked products. However, frequently, isotope labeling complicates the mass spectra of products, increases the possibility of peak overlap, and lowers the possibility of cross-linked products being detected by mass spectrometry due to ion suppression effects. In addition, incomplete labeling, for example due to partial label 18 O exchange in proteolytic digestion samples, distorts the natural isotopic distribution. 47 Platinum has advantages over isotope labeling because it has a normalized unique isotopic distribution ( 194 Pt (97.41%),
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Pt (100%);
196 Pt (74.58%)), which allows for easy visual identification of cross-linked products in a spectrum without significantly complicating the spectrum or the need for intricate labeling procedures. 48 As presented in Figure 3a , a Pt-bound peptide complex has a broader and more abundant isotopic distribution compared to unlabeled peptides in the same m/z region (CaM (38-74) ). Peak results are listed in Table S-3 (CAD) and Table S 
